Drug intelligence / Profile preview

Cystorax

Development stage: Unknown
Lead developer: Rax Health Care
Administration: Oral

Overview

Cystorax is an Ayurvedic polyherbal formulation developed by Rax Health Care Private Limited, primarily indicated for the management of urinary tract and kidney-related conditions such as renal calculi (kidney stones) and urinary tract infections. Available in capsule and syrup forms, the product contains a blend of traditional Ayurvedic ingredients including Gokshura (*Tribulus terrestris*), Punarnava (*Boerhavia diffusa*), Pashan Bhed (*Bergenia ligulata*), and Shudh Shilajit. These components are traditionally recognized for their diuretic, lithontriptic (stone-dissolving), and anti-inflammatory properties, which help in flushing the urinary tract and supporting overall renal health.

Brand names: Cystorax

Beyond the preview

Go deeper on Cystorax.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cystorax.

Explore the full profile